id
name
processing priority
4
site type
0 (generic, awaiting analysis)
review version
11
html import
0 (new)
first seen date
2024-08-23 09:22:38
expired found date
-
created at
2024-08-23 09:22:38
updated at
2026-02-02 13:02:05
length
14
crc
50237
tld
2211
nm parts
0
nm random digits
0
nm rare letters
0
is subdomain of id
23989646 (corcept.com)
previous id
0
replaced with id
0
related id
-
dns primary id
0
dns alternative id
0
lifecycle status
0 (unclassified, or currently active)
deleted subdomains
0
page imported products
0
page imported random
0
page imported parking
0
count skipped due to recent timeouts on the same server IP
2
count content received but rejected due to 11-799
0
count dns errors
1
count cert errors
0
count timeouts
2
count http 429
0
count http 404
0
count http 403
0
count http 5xx
0
next operation date
2026-02-04 17:02:05
server bits
—
server ip
mp import status
20
mp rejected date
-
mp saved date
2025-12-24 13:39:04
mp size orig
72073
mp size raw text
2658
mp inner links count
14
mp inner links status
10 (links queued, awaiting import)
title
Investor Relations – Corcept Therapeutics, Incorporated
description
The Investor Relations website contains information about Corcept Therapeutics, Incorporated's business for stockholders, potential investors, and financial analysts.
image
site name
Corcept Therapeutics, Incorporated
author
updated
2026-02-20 22:08:35
raw text
Investor Relations – Corcept Therapeutics, Incorporated Skip to main navigation Home About Our Team Stories Careers Products Science Pipeline and Clinical Trials Cortisol Modulation Therapeutic Areas Publications Investigator Initiated Studies Resources Medical Information Request Grants Compassionate use State Required Notice Investors Overview Press Releases Events Corporate Governance Analyst Coverage Stock Information SEC Filings Privacy Notice Old Terms of Use Site Map Menu Menu Contact Search Investor Relations Company Profile Corcept Therapeutics is a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol. Corcept has a large portfolio of proprietary compounds that selectively modulate the effects of cortisol but not progesterone. Corc...
redirect type
0 (-)
block type
0 (no issues)
detected language
1 (English)
category id
-
index version
1
spam phrases
0
text nonlatin
0
text cyrillic
0
text characters
1949
text words
321
text unique words
189
text lines
87
text sentences
5
text paragraphs
1
text words per sentence
64
text matched phrases
0
text matched dictionaries
0
links self subdomains
0
links other subdomains
links other domains
21 - corcept.com
links spam adult
0
links spam random
0
links spam expired
0
links ext activities
0
links ext ecommerce
0
links ext finance
0
links ext crypto
0
links ext booking
0
links ext news
0
links ext leaks
0
links ext ugc
1 - linkedin.com
links ext klim
0
links ext generic
0
dol status
0
dol updated
2026-02-20 22:08:35
rss path
rss status
0 (new)
rss found date
-
rss size orig
0
rss items
0
rss spam phrases
0
rss detected language
0 (awaiting analysis)
inbefore feed id
-
inbefore status
0 (new)
sitemap path
sitemap status
0 (new)
sitemap review version
2
sitemap urls count
0
sitemap urls adult
0
sitemap filtered products
0
sitemap filtered videos
0
sitemap found date
-
sitemap process date
-
sitemap first import date
-
sitemap last import date
-